news2026-08-30T15:40:30+00:00#ESC26: Arrowhead claims safety edge over Ionis as triglyceride battle draws closer
news2026-08-30T07:19:28+00:00#ESC26: AstraZeneca’s relaxin pill shows promise in mid-stage heart failure trial